Johnson Marvin 4
4 · MARINUS PHARMACEUTICALS, INC. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Johnson Marvin
Director
Transactions
- Award
Common Stock
2024-06-18+2,300→ 14,100 total - Award
Stock Option (Right to Buy)
2024-06-18+10,450→ 10,450 totalExercise: $1.40Exp: 2034-06-18→ Common Stock (10,450 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
- [F2]The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer.